24 Feb New study extends lutein’s ‘functional evidence’ for eye health benefits
Increased intakes of lutein may not only have a direct beneficial role in the macula of the eye, but may also affect inflammation, says a new study.
Results from a one year study indicated that 10 mg per day of lutein indicated that supplementation with the carotenoid significantly reduced levels of sC5b-9, a marker of systemic inflammation, compared to placebo.
“This study is the first to show that an increased dietary intake of lutein reduces the plasma level of sC5b-9,” wrote scientists from the University Eye Clinic Maastricht in The Netherlands and the University of Manchester in England.
“Due to the important role of the complements system as a mediator of
inflammation and its role in the pathogenesis of AMD, lutein
supplementation can be considered as a potential prevention and
treatment for AMD.”